EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Emerging Role of Janus Kinase Inhibitors in Treating Granuloma Annulare: A Clinical, Narrative Review of Efficacy and Safety

Sama Heidari iD, Reza Omid iD, Hanie Babaie iD, Zeinab Aryanian iD

International Journal of Dermatology · 2025

DOI: 10.1111/ijd.17684 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Dermatology, 2025. Verfasst von Sama Heidari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Janus Kinase Inhibitors, Granuloma Annulare, Janus Kinases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Granuloma annulare (GA) is a non‐infectious, granulomatous skin disease with an unknown pathoetiology whose treatment remains challenging. In recent decades, the Janus kinase‐signal transducers and activators of transcription (JAK–STAT) pathway have been implicated in the pathogenesis of various skin diseases, including GA. This pathway involves T‐helpers and macrophages, launching a cytokine cascade that plays a crucial role in the disease pathology. Janus kinase (JAK) inhibitors can prevent cytokine involvement. To date, limited clinical data has been reported about the effectiveness of JAK inhibitors on granulomatous diseases. This review aims to examine studies that have reported off‐label use of different JAK inhibitors in treating GA, focusing on their effectiveness and safety. Since there is no definitive treatment for GA, evaluating the role of JAK inhibitors could help establish a consensus on their future use in this type of medication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Janus Kinase InhibitorsGranuloma AnnulareJanus KinasesHumansTreatment OutcomeAzetidinesNitrilesPiperidinesPyrimidinesPurinesPyrazolesTriazolesSulfonamides

Stichwörter der Autor:innen

JAK inhibitorsJanus kinase inhibitorcytokinesgranuloma annularegranulomatous disease

Substanzen

Janus Kinase InhibitorsbaricitinibJanus KinasestofacitinibAzetidinesNitrilesPiperidinesPyrimidinesPurinesPyrazoles

Autor:innen und Institutionen

  • Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Sama Heidari, Reza Omid, Hanie Babaie, Zeinab Aryanian

Zitieren

APA

Heidari, S., Omid, R., Babaie, H., & Aryanian, Z. (2025). Emerging Role of Janus Kinase Inhibitors in Treating Granuloma Annulare: A Clinical, Narrative Review of Efficacy and Safety. International Journal of Dermatology. https://doi.org/10.1111/ijd.17684

Vancouver

Heidari S, Omid R, Babaie H, Aryanian Z. Emerging Role of Janus Kinase Inhibitors in Treating Granuloma Annulare: A Clinical, Narrative Review of Efficacy and Safety. International Journal of Dermatology. 2025. doi:10.1111/ijd.17684

BibTeX
@article{Heidari2025,
  author = {Heidari, Sama and Omid, Reza and Babaie, Hanie and Aryanian, Zeinab},
  title = {Emerging Role of Janus Kinase Inhibitors in Treating Granuloma Annulare: A Clinical, Narrative Review of Efficacy and Safety},
  journal = {International Journal of Dermatology},
  year = {2025},
  doi = {10.1111/ijd.17684}
}
Kostenlos starten →